Mossler Mark 4
4 · C4 Therapeutics, Inc. · Filed Apr 10, 2024
Insider Transaction Report
Form 4
Mossler Mark
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-14+27,430→ 27,430 totalExercise: $7.31Exp: 2034-02-13→ Common Stock (27,430 underlying) - Award
Common Stock
2024-02-14+18,290→ 19,790 total
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2025.
- [F2]Includes 1,500 shares of Common Stock that were inadvertently omitted from the Form 3 filed by the Reporting Person on September 19, 2023.
- [F3]The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2024.